CAS: 28523-86-6; Sevoflurane

结构式图片

欧盟法规

[ECHA物质

上下游产品

CAS号26103-07-1 2-(氯甲氧基)-1,1,1,... | CAS号373-53-5 氟碘甲烷 | CAS号920-66-1 六氟异丙醇 | CAS号373-52-4 氟溴甲烷 | CAS号593-70-4 氯氟甲烷 | CAS号406-58-6 1,1,1,3,3-五氟丁烷 | CAS号50-00-0 甲醛 | CAS号1152045-94-7 methyl 3,3,3-tr... | CAS号97614-43-2 2-脱氧-2-氟-1,3,5-... | CAS号26103-07-1 2-(氯甲氧基)-1,1,1,... | CAS号13171-18-1 六氟异丙基甲醚 | CAS号58109-34-5 1,1,3,3,3-五氟-2-...

合成工艺路线路线简述

    二氯甲基醚置于brf3体系中,化学反应生成七氟烷
    参考文献:Method For The Preparation Of Fluoromethyl
    标题:Method For The Preparation Of Fluoromethyl
    摘要:氟甲基-1,1,1,3,3,3-六氟-2-丙基醚的制备是通过溴三氟和甲基-1,1,1,3,3,3-六氯-2-丙基醚或氯甲基-1,1,1,3,3,3-六氯-2-丙基醚反应得到的.具有公式##str1##(其中x+y=3,A+b=3,Z=h Cl或f)的混合氟氯醚中间体通过与溴三氟反应转化为氟甲基-1,1,1,3,3,3-六氟-2-丙基醚.

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-7375254-B2
    优先权日:2003-01-14
    标题:Process for recovery of 1,1,1,3,3,3-hexafluoroisopropanol from the waste stream of sevoflurane synthesis
    发明人:ROZOV LEONID A; LESSOR RALPH A
    权利人:BAXTER INT
    摘要:Provided is a process of obtaining 1,1,1,3,3,3-hexafluoro-2-propanol (“HFIPâ€?) from a composition comprising an HFIP hydrolyzable precursor. The HFIP hydrolyzable precursor is a compound, other than sevoflurane itself, that has an intact 1,1,1,3,3,3-hexafluoroisopropoxy moiety[(CF 3 ) 2 CHO—], and contains one or more moieties susceptible to acidic hydrolysis, such that HFIP is released upon such treatment. The process is useful, among other things, for recovering HFIP from waste streams associated with the synthesis of the inhalation anesthetic, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether (“sevofluraneâ€?). The process includes heating the composition with a strong protic acid to a temperature effective to hydrolyze at least some of the HFIP hydrolyzable precursor to HFIP, and then isolating the HFIP from the heated composition.

    专利号:US-5705710-A
    优先权日:1997-01-15
    标 题 :Process for the synthesis of hexafluoroisopropyl ethers
    发明人:BAKER MAX T; TINKER JOHN H; RUZICKA JAN A
    权利人:UNIV IOWA RES FOUND
    摘要:This invention relates to a method of synthesizing 1,1,1,3,3,3-hexafluoroisopropyl ether compounds from the reaction of methoxymalanonitrile with a bromine trifluoride composition.

    专利号:US-5789630-A
    优先权日:1996-02-27
    标题:Process for the synthesis of hexafluoropropanes
    发明人:BAKER MAX T; RUZICKA JAN A
    权利人:UNIV IOWA RES FOUND
    摘要:The invention relates to a method of synthesizing 1,1,1,3,3,3-hexafluoropropanes comprsing the additon of BrF 3 to malononitrile.

    专利号:US-2015352230-A1
    优先权日:2013-01-11
    标 题:Synthesis and isolation of dendrimer based imaging systems
    发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK
    权利人:UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

    专利号:US-7605291-B2
    优先权日:2006-04-27
    标 题 :Method for the preparation of volatile Anesthetics
    发明人:MALDONADO ADALBERTO
    权利人:MALDONADO ADALBERTO
    摘要:The present invention is concerned with the automated control of the synthesis and purification of components useful in the synthesis and purification of volatile anesthetics. The invention is particularly useful in its application to the purification of acetone used in the purification of isoflurane.
    济南晟齐医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.shengqipharm.com
    电话: 0531-88891987👤
    📞济南晟齐医药科技有限公司 ⚠️参考联系方式

    销售电话:0531-88891987
    邮箱:janice@shengqipharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏宇田医药股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jsytsw.com
    企业联系电话:0518-86098000;86098017👤
    📞江苏宇田医药股份有限公司 ⚠️参考联系方式
    联系人:王先生;樊女士
    电话:0518-86098000;86098017
    手机:15261372765;18861350683

    邮箱:sales@jsytsw.com
    通信地址: 江苏连云港市经济技术开发区大浦工业区临浦路22号
    邮编: 222000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏连云港市经济技术开发区大浦工业区临浦路22号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00540-010-0889-2
    摘要:Shiotsuka J, Sanui M, Lefor A. Safe use of landiolol hydrochloride in a patient with marked pseudocholinesterase deficiency. Journal of Anesthesia. 2010 Feb 13;24(2):309–10. doi: 10.1007/s00540-010-0889-2.
    参考文献:10.1186/cc8875
    摘要:Mayer J, Boldt J, Mengistu AM, Röhm KD, Suttner S. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients: a randomized, controlled trial. Crit Care. 2010;14(1):R18.
    参考文献:10.1016/j.joms.2008.12.012
    摘要:Rossi A, Falzetti G, Donati A, Orsetti G, Pelaia P. Desflurane Versus Sevoflurane to Reduce Blood Loss in Maxillofacial Surgery. Journal of Oral and Maxillofacial Surgery. 2010 May;68(5):1007–12. doi: 10.1016/j.joms.2008.12.012.
    参考文献:10.1007/s00259-010-1392-6
    摘要:Eder M, Knackmuss S, Le Gall F, Reusch U, Rybin V, Little M, Haberkorn U, Mier W, Eisenhut M. 68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours. European Journal of Nuclear Medicine and Molecular Imaging. 2010 Feb 16;37(7):1397–407. doi: 10.1007/s00259-010-1392-6.
    参考文献:10.1007/s00259-010-1384-6
    摘要:Schoultz BW, Hjornevik T, Willoch F, Marton J, Noda A, Murakami Y, Miyoshi S, Nishimura S, Årstad E, Drzezga A, Matsunari I, Henriksen G. Evaluation of the kappa-opioid receptor-selective tracer [11C]GR103545 in awake rhesus macaques. European Journal of Nuclear Medicine and Molecular Imaging. 2010 Feb 16;37(6):1174–80. doi: 10.1007/s00259-010-1384-6.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知